Home
About
Services
Partners
Client Portfolio
News
Contact
Oil prices drop on swelling oversupply, volatile markets
January 3, 2019
Apple warning shakes European shares as chipmakers tumble
January 3, 2019
0
U.S. drugmaker J&J’s India sales dip 3 percent in 2017/18: filing
Published by
Muller&Green
at
January 3, 2019
Categories
RSS
Tags
Johnson & Johnson’s sales in India dipped 3 percent in the year to March 2018, a regulatory filing showed on Thursday, as the U.S. drugmaker grappled with the country’s stringent medical device pricing policies.
Powered by
WPeMatico
Muller&Green
Related posts
June 18, 2020
Chanel warns virus impact will linger on luxury sector
Read more
June 18, 2020
IMF says deeper-than-expected contraction in U.S. economy likely in second quarter
Read more
June 18, 2020
Prudential sells Jackson equity stake to Apollo-backed Athene for $500 million
Read more